Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 86 member D, pseudogene (FAM86DP), is classified as a pseudogene in the human genome and does not encode a functional protein. Pseudogenes, once considered "junk DNA," are now understood to potentially have regulatory functions at the RNA level, such as acting as microRNA decoys, producing regulatory noncoding RNAs, or influencing the expression of related genes through antisense transcripts or competition for RNA stability factors[2]. Despite extensive associations with various biological entities in data-mining resources, FAM86DP itself lacks direct evidence for therapeutic targeting, biological activity, or disease involvement as a conventional drug target[1][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 86 member D, pseudogene (FAM86DP).